{"id":646338,"date":"2023-04-10T19:52:01","date_gmt":"2023-04-10T19:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=646338"},"modified":"2023-04-10T19:52:01","modified_gmt":"2023-04-10T19:52:01","slug":"palmar-fibromatosis-market-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-market","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/palmar-fibromatosis-market-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-market_646338.html","title":{"rendered":"Palmar Fibromatosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market"},"content":{"rendered":"
\n
\"Palmar<\/a><\/div>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Palmar Fibromatosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Palmar Fibromatosis, historical and forecasted epidemiology as well as the Palmar Fibromatosis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n

DelveInsight’s “Palmar Fibromatosis Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>” report delivers an in-depth understanding of the Palmar Fibromatosis, historical and forecasted epidemiology as well as the Palmar Fibromatosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

The Palmar Fibromatosis market report provides current treatment practices, emerging drugs, Palmar Fibromatosis market share of the individual therapies, current and forecasted Palmar Fibromatosis market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Palmar Fibromatosis treatment practice\/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Palmar Fibromatosis market.<\/p>\n

Palmar Fibromatosis Overview<\/strong><\/p>\n

Plantar fascial fibromatosis, also known as Ledderhose’s disease, Morbus Ledderhose, and plantar fibromatosis, is a relatively uncommon]<\/a> non-malignant thickening of the feet’s deep connective tissue, or fascia. In the beginning, where nodules start growing in the fascia of the foot the disease is minor. Over time walking becomes painful. The disease is named after Georg Ledderhose, a German surgeon who described the condition for the first time in 1894. A similar disease is Dupuytren’s disease, which affects the hand and causes bent hands or fingers.<\/p>\n

As in most forms of fibromatosis, it is usually benign and its onset varies with each patient. The nodules are typically slow growing and most often found in the central and medial portions of the plantar fascia.]<\/a> Occasionally, the nodules may lie dormant for months to years only to begin rapid and unexpected growth. Options for intervention include radiation therapy, cryosurgery, treatment with collagenase clostridium histolyticum, or surgical removal only if discomfort hinders walking<\/p>\n

\"\"<\/p>\n

Palmar Fibromatosis Epidemiology Insights<\/strong><\/p>\n

The disease is more commonly associated with –<\/p>\n